Addus HomeCare Q2 2026: Revenue Climbs 8% to $377M, Adjusted EPS of $1.73 Beats by 16%
ADUS sits 28% above its 52-week low of $87.95.
Summary
Addus HomeCare reported Q2 2026 revenue of $377.4 million, up 8% year-over-year, with adjusted EPS of $1.73 beating the prior year by 16.1%. Strong organic growth in personal care and hospice, coupled with rate increases and a recent acquisition, drove the outperformance.
Key Events · Earnings and Guidance · ADUS
-
Revenue and Earnings Beat
Q2 2026 net service revenues rose 8.0% to $377.4 million, with net income of $27.6 million ($1.49 diluted EPS). Adjusted diluted EPS of $1.73 exceeded the prior year's $1.49 by 16.1%.
-
Segment Growth Drivers
Personal care organic revenue grew 6.8%, aided by rate increases in Texas (9.9%) and Illinois (3.9%). Hospice organic revenue jumped 11.1% on higher average daily census and revenue per patient day. Home health organic revenue declined 2.8%.
-
Cash Flow and Balance Sheet Strength
Operating cash flow was $40.0 million for Q2 2026, nearly double the prior year. Cash stood at $99.6 million with bank debt of $64.3 million and $577.8 million available under the revolving credit facility as of June 30, 2026.
-
Acquisition and M&A Outlook
The acquisition of HomeCourt Home Care on May 1, 2026, contributed two months of operations. Management highlighted a strong balance sheet and low leverage to pursue further targeted acquisitions to enhance market density.
Analysis · ADUS · Industrial Applications And Services
A strong second quarter for Addus HomeCare saw revenue rise 8% to $377.4 million, while adjusted earnings per share surged 16.1% to $1.73. The personal care segment delivered 6.8% organic revenue growth, lifted by rate increases in Texas and Illinois, and hospice organic revenue jumped 11.1%. Operating cash flow nearly doubled year-over-year to $40 million, and the balance sheet remains robust with $99.6 million in cash and low leverage. These results highlight the company's ability to drive profitable growth in the home care market, though the home health segment continues to lag with a 2.8% organic revenue decline. The acquisition of HomeCourt Home Care contributed two months of operations, and management signaled continued appetite for M&A to build density. With a conference call tomorrow, investors will look for commentary on the sustainability of these trends and the pipeline for further acquisitions.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 29.6% of the 1716 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.32%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ADUS was trading at $112.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $87.95 to $124.44. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.